Resuming Coverage on PetVivo (PETV).
After Being up 1,035%, Raising $11 Million, Upgrading to NASDAQ, and Retreating 87% From its High, we Resume Coverage.
Citius Pharma (CTXR) Flexes Muscle in Business Update. Remains Our Top Idea.
Added to Watch List November 2019 @$0.55.
Named Our Top Idea in 2020 @$1.02.Remains Our Top Idea in 2021...
Telehealth: Contactless Health Screening from Ehave (EHVVF) and VastMinz.
Contactless Health Screening
Ehave acquires License covering G-20 Countries for all Psychedelic use, AI-Powered Telehealth Technology To Capture Physiological...
Dyadic (DYAI) Scores $10M deal with Sorrento Therapeutics (SNRE).
Share Price up 27% ($4.63 up $1.04) as Wall Street Sorts out the Terms of the Deal.
We've had...
Hapbee (HAPB) Expands Leadership Team to Support Aggressive Growth Strategy
VANCOUVER, BC, Aug. 6, 2021 /CNW/ - Hapbee Technologies, Inc. (TSXV: HAPB) (OTCQB: HAPBF) (FSE: HA1) ("Hapbee" or the "Company"), the leading wearable, wellness technology company has...
With Hapbee (HAPBF) Who Needs, Drugs, Caffeine or Nicotine?
Record 1 Million Hours of Mood Stimulation Served by Hapbee (HAPBF).
TRADING AT THE LOWER END OF...
Are Psychedelics the New Prozac?
Amidst a national epidemic of opioid abuse, and suicides the need for new therapeutics has gained greater urgency. In it's first step to...
Cybin (CLXPF CYBN) Gets $8.00 Price Target From H.C. Wainwright.
Advancing Multiple Psychedelics in Multiple Indications; Initiating With a Buy and $8 Price Target.
Atai Life Sciences (ATAI) Founder Christian Angermayer Interview.(VIDEO)
Best Psychedelic related interview we've seen yet. Christian states, "I think ultimately, the total addressable market is 100% of the world population!"
I Use Ketamine for Depression – Here’s How It Works.
FREETHINK: When first manufactured as an anesthetic for humans and animals in 1962, doctors had no intention of prescribing ketamine for depression....